{"data":{"responsecode":"000","responsemsg":"","quote":{"hi":"1.080","rs_stock_flag":false,"fiscal_year_end":"2024年12月31日","hist_closedate":"2025年9月25日","replication_method":null,"amt_os":"512,582,000","primaryexch":"香港交易所","ric":"6118.HK","product_subtype":null,"db_updatetime":"2025年9月28日08:06","mkt_cap_u":"M","am_u":"K","ew_sub_right":"","secondary_listing":false,"ew_amt_os_cur":null,"ccy":"HKD","management_fee":"","ew_underlying_code":null,"trdstatus":"N","nav":"","original_offer_price":"","issue":"","asset_class":null,"eps":0.0314,"inline_upper_strike_price":"","sedol":"BSHYHZ4","am":"510.80","iv":"","ew_strike":"","as":"1.070","geographic_focus":null,"incorpin":"開曼群島","etp_baseCur":null,"ew_amt_os":"","bd":"1.030","registrar":"卓佳證券登記有限公司","depositary":null,"exotic_type":null,"callput_indicator":null,"primary_market":null,"underlying_index":null,"lot":"1,000","update_time":"2025-09-28 00:06:03.0","lo52":"0.450","shares_issued_date":"2025年8月31日","premium":"","strike_price_ccy":null,"yield":"","vo_u":"K","base_currency":null,"coupon":"","expiry_date":"","chairman":"何國強","underlying_ric":"6118.HK","hi52":"1.970","issuer_name":"奧星生命科技有限公司","h_share_flag":false,"ew_sub_per_from":"","div_yield":"","interest_payment_date":"-","updatetime":"2025年9月26日16:08","aum_date":"","lo":"1.020","mkt_cap":"527.95","f_aum_hkd":null,"ew_sub_per_to":"","ls":"1.030","nav_date":"","csic_classification":null,"floating_flag":false,"issued_shares_note":null,"nom_ccy":null,"eff_gear":"","board_lot_nominal":null,"hsic_ind_classification":"醫療保健業 - 藥品及生物科技","ew_desc":null,"inception_date":"","nc":"-0.040","aum":"","issued_shares_class_B":null,"vo":"488.00","secondary_listing_flag":false,"listing_date":"2014年11月7日","issued_shares_class_A":null,"as_at_label":"截至","ew_amt_os_dat":"","nm":"奧星生命科技有限公司","nm_s":"奧星生命科技","sym":"6118","inline_lower_strike_price":"","listing_category":"主要上市","ew_strike_cur":null,"exotic_warrant_indicator":null,"investment_focus":null,"call_price":"","tck":"0.010","strike_price":"","summary":"奧星生命科技有限公司是一家主要從事提供一體化工程解決方案，以及製造及分銷製藥設備及耗材的投資控股公司。該公司經營六個分部：流體與生物製程系統分部、無塵室及自動化控制與監控系統分部、粉體固體系統分部、GMP合規性服務分部、生命科技耗材分部及製藥設備經銷及代理分部。該公司的產品包括無塵公用工程設備與系統、生物製程設備及系統、粉固體設備及系統、製藥製程污染控制產品、包裝及密閉轉運產品、生物安全及實驗動物設備及耗材等。","op":"1.070","aum_u":"","nav_ccy":null,"class_B_description":null,"os":"","wnt_gear":"","transfer_of_listing_date":"","hsic_sub_sector_classification":"生物技術","amt_ccy":null,"class_A_description":null,"domicile_country":null,"entitlement_ratio":"","product_type":"EQTY","office_address":"香港新界<br/>沙田安平街6號<br/>新貿中心<br/>1樓6室","pc":"-3.74","days_to_expiry":null,"underlying_code":null,"pe":"31.02","eps_ccy":"RMB","hdr":false,"launch_date":"","hc":"1.070","isin":"KYG0632L1023","moneyness":""}},"qid":"1759074803296"}
